Christian Henrik Tange
Direttore/Membro del Consiglio presso KDev Investments AB
Profilo
Christian Henrik Tange is currently a Director at KDev Investments AB.
He was previously a Chairman at Dilafor AB, Director at Promimic AB, Director at Xspray Pharma AB, and Director at KDev Oncology AB.
From 2014 to 2017, he served as the Chief Financial Officer at Karolinska Development AB (Private Equity) and from 2018 to 2020, he was the Chief Financial Officer at Agillic A.
He also served as the Chief Financial Officer at Karolinska Development AB from 2014 to 2017.
Prior to that, he was the Chief Financial Officer at AGC Biologics A from 2003 to 2012 and a Business Controller at Warner Lambert Nordic AB from 1997 to 2000.
He received his undergraduate and graduate degrees from Copenhagen Business School.
Posizioni attive di Christian Henrik Tange
Società | Posizione | Inizio |
---|---|---|
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Christian Henrik Tange
Società | Posizione | Fine |
---|---|---|
AGILLIC A/S | Direttore Finanziario/CFO | 01/09/2020 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Direttore Finanziario/CFO | 30/11/2017 |
KAROLINSKA DEVELOPMENT AB | Direttore Finanziario/CFO | 29/08/2017 |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Direttore Finanziario/CFO | - |
Warner Lambert Nordic AB | Corporate Officer/Principal | - |
Formazione di Christian Henrik Tange
Copenhagen Business School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
AGILLIC A/S | Technology Services |
PROMIMIC AB | Health Technology |
XSPRAY PHARMA AB | Health Technology |
KAROLINSKA DEVELOPMENT AB | Finance |
Aziende private | 6 |
---|---|
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Finance |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Health Technology |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Health Technology |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Commercial Services |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Health Technology |
Warner Lambert Nordic AB |
- Borsa valori
- Insiders
- Christian Henrik Tange